Fundraising Fox

Nicholas Siciliano

Venture Advisor at Agent Capital

About

A biotech executive with twenty years of C-suite experience who co-founded and led molecular diagnostics company Invisible Sentinel through its acquisition by bioMerieux. He serves on the boards of Vittoria Biotherapeutics and NexEOS Bio.

Colleagues at Agent Capital